Evidence map›Paper›PMID 21629864›Full record

ArticleInternational journal of hypertension2011

Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension.

Vasilios Papademetriou, Michalis Doumas, Konstantinos Tsioufis

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in International journal of hypertension, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04055285 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Effect of Renal Denervation on Atrial Fibrillation

TypeinterventionalSponsorHippocration General HospitalRan2020 to 2022Enrolled30ConditionsArterial Hypertension, Atrial FibrillationArmsSympathetic Renal Denervation, Implantable Loop Recorder
NCT05438446 phase2completednot on this mapstarted 2021, after this paper: background citation

Effect of Renal Denervation on Stress, Hypertension and Anxiety Management (ERSHAM Study) in Patients With Uncontrolled Hypertension

TypeinterventionalSponsorHippocration General HospitalRan2021 to 2026Enrolled60ConditionsHypertension Arterial, Anxiety, StressArmsEndovascular ultrasound renal denervation (Paradise renal denervation system, ReCor, CA, USA) (RDN)
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. The denervation or activation of renal sympathetic nerve and renal blood flow.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2023
    Review
  4. Review
  5. Baroreflex gain and vasomotor sympathetic modulation in resistant hypertension.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2017
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Dilemmas in treating hypertension in octogenarians.Journal of clinical hypertension (Greenwich, Conn.) · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Vasilios PapademetriouVeterans Affairs and Georgetown University Medical Centers, 50 Irving Street, Washington, DC 20422, USA.
Michalis Doumas
Konstantinos Tsioufis
Aristotle University of Thessaloniki · GRGeorgetown University · USNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension represents a major health problem with an appalling annual toll. Despite the plethora of antihypertensive drugs, hypertension remains resistant in a considerable number of patients, thus creating the need for alternative strategies, including interventional approaches. Recently, catheter-based renal sympathetic denervation has been shown to be fairly safe and effective in patients with resistant hypertension. Pathophysiology of kidney function, interaction and crosstalk between the kidney and the brain, justifies the use of renal sympathetic denervation in the treatment of hypertension. Data from older studies have shown that sympathectomy has effectively lowered blood pressure and prolonged life expectancy of hypertensive patients, but at considerable cost. Renal sympathetic denervation is devoid of the adverse effects of surgical sympathectomy, due to its localized nature, is minimally invasive, and provides short procedural and recovery times. This paper outlines the pathophysiological background for renal sympathetic denervation, describes the past and the present of this interventional approach, and considers several future potential applications.

Identifiers

PMID21629864
PMCPMC3095896
OpenAlexW1980169002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.